SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-059044
Filing Date
2023-07-24
Accepted
2023-07-24 09:02:59
Documents
15
Period of Report
2023-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182176-8k_abvcbio.htm   iXBRL 8-K 49469
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION ea182176ex3-1_abvcbio.htm EX-3.1 5120
3 PRESS RELEASE, DATED JULY 21, 2023 ea182176ex99-1_abvcbio.htm EX-99.1 13331
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5737
  Complete submission text file 0001213900-23-059044.txt   259591

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abvc-20230724.xsd EX-101.SCH 3021
6 XBRL LABEL FILE abvc-20230724_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE abvc-20230724_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT ea182176-8k_abvcbio_htm.xml XML 3325
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231103871
SIC: 2834 Pharmaceutical Preparations